June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Inflammatory Markers and Age-related Macular Degeneration: Findings from an Older Cataract Surgical Cohort
Author Affiliations & Notes
  • Jie Jin Wang
    Ctr for Vision Research/Ophthalmol, University of Sydney, Westmead, NSW, Australia
    Centre for Eye Research Australia, Department of Ophthalmology, University of Melbourne, Melbourne, VIC, Australia
  • Calvin Fong
    Ctr for Vision Research/Ophthalmol, University of Sydney, Westmead, NSW, Australia
  • Elena Rochtchina
    Ctr for Vision Research/Ophthalmol, University of Sydney, Westmead, NSW, Australia
  • Ava Tan
    Ctr for Vision Research/Ophthalmol, University of Sydney, Westmead, NSW, Australia
  • Paul Mitchell
    Ctr for Vision Research/Ophthalmol, University of Sydney, Westmead, NSW, Australia
  • Footnotes
    Commercial Relationships Jie Jin Wang, None; Calvin Fong, None; Elena Rochtchina, None; Ava Tan, None; Paul Mitchell, Novartis (R), Bayer (R)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 368. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jie Jin Wang, Calvin Fong, Elena Rochtchina, Ava Tan, Paul Mitchell; Inflammatory Markers and Age-related Macular Degeneration: Findings from an Older Cataract Surgical Cohort. Invest. Ophthalmol. Vis. Sci. 2013;54(15):368.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate the associations between inflammatory markers and incidence of early and late age-related macular degeneration (AMD) in a cataract surgical cohort.

 
Methods
 

We followed cataract surgical patients from Westmead Hospital, Sydney, aged 64+ years for 5 post-operative years in the Australian Cataract Surgery and Age Related Macular Degeneration (CSAMD) Study. We performed annual examinations with retinal photography to assess incident AMD using a side-by-side grading method. Preoperative and one-month postoperative images provided baseline information. Incident early AMD was defined as the new appearance of either indistinct soft/reticular drusen or co-existing retinal pigmentary abnormality and distinct soft drusen, in persons without early AMD in either eye at baseline. Incident late AMD was defined as the new appearance of neovascular AMD or geographic atrophy in persons without previous late AMD in either eye. White cell count (WCC), high sensitive C-reactive protein (hs-CRP) and fibrinogen were assessed from blood taken 3-5 years after surgery.

 
Results
 

Of 1930 patients recruited, 1597 (82.7%) were followed up for 1 to 5 years postoperatively; 1277 (80.0% of 1579) had gradable retinal images at baseline and follow-up visits and were at risk of late AMD. Of the 1277, 791 (61.9%) had blood samples taken. Median (interquartile range) values were: WCC, 6.90 (5.80-8.20) x10-9/L; hs-CRP, 2.31 (1.08-4.65) mg/L; fibrinogen, 3.60 (3.10-4.10) g/L. Of 1277 at risk, 45 developed late AMD. Of 921 at risk, 143 developed early AMD. After adjusting for age, sex and current smoking, WCC above the median was associated with increased risk of late AMD (odds ratio, OR, 2.21, 95% confidence interval, CI, 1.04-4.73); hs-CRP above the median was associated with increased risk of early AMD (OR 1.64, 95% CI 1.08-2.48); additional adjustment for hs-CRP in the model for late AMD, or WCC in the model for early AMD, did not alter these associations. Further adjustment for baseline large drusen and retinal pigment abnormalities weakened the association of WCC with late AMD (OR 1.84, 95% CI 0.84-1.05). Fibrinogen was not associated with early or late AMD incidence.

 
Conclusions
 

The specific associations of WCC with late AMD and hs-CRP with early AMD suggest different inflammatory processes leading to late and early AMD in patients after cataract surgery.

 
Keywords: 412 age-related macular degeneration • 557 inflammation • 464 clinical (human) or epidemiologic studies: risk factor assessment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×